Responses
Editorial
Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015A proposal for eplerenone in aortic stenosisShow More
Dear Editor,
For the sake of completeness, the thesis that the renin-angiotensin- aldosterone system (RAAS) might have a role in the pathogenesis of aortic stenosis[1], also requires a recognition that angiotensin converting enzyme(ACE)inhibitor therapy[2] might, on its own, be insufficient to retard progression of this disorder, and that a cardioprotective component specifically targeting aldosterone blockade by co...
Conflict of Interest:
None declared.